Minimal profits projected for Duopharma from vaccines

Duopharma on Friday received a conditional registration approval for the vaccine and is likely to sign an agreement by month-end with more details to be announced then.

PETALING JAYA: Earnings contribution for the potential supply of Sinopharm Covid-19 vaccine to the government by Duopharma Biotech Bhd is expected to be marginal.

The company on Friday received a conditional registration approval for the vaccine and is likely to sign an agreement by month-end with more details to be announced then.